Roche sales increase 1%Christian Fernsby ▼ | July 23, 2020
Roche Group sales increase 1% constant exchange rates and decline 4% in Swiss francs as a result of continued appreciation of the Swiss franc against most currencies.
Sales decreased in Japan 2%, resulting from considerable competition from biosimilars, generics and government price cuts.
Diagnostics Division sales increased 3% to CHF 6.1 billion. The business area Molecular Diagnostics (+61%) was the main growth contributor. ■